awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33415731-AAABAD6C-B33B-461B-92E5-83B1F4B8EDC5
Q33415731-AAABAD6C-B33B-461B-92E5-83B1F4B8EDC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415731-AAABAD6C-B33B-461B-92E5-83B1F4B8EDC5
Safety evaluation of ruxolitinib for treating myelofibrosis.
P2860
Q33415731-AAABAD6C-B33B-461B-92E5-83B1F4B8EDC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415731-AAABAD6C-B33B-461B-92E5-83B1F4B8EDC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
453b5420189a534c55fd74a72fdf8af2d4fb7a17
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.